(1) Greenber S, Frishman WH. Co-enzyme Q10: A New Drug for
Cardiovascular Disease. J Clin
Pharmacol. 1990;30:596-608.
(2) Stryer, Lubert. Biochemistry, 4th Ed. New York:
W.H. Freeman and
Company, 1995; pg 535-537.
(3) Folkers K, Vadhanavikit S, Mortensen SA. Biochemical rational
and
myocardial tissue data on the effective
therapy of cardiomyopathy with
coenzyme Q10. Proc Natl Acad Sci U S
A. 1985;82:901-4
(4) Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS,
et al. Increased oxidative stress in
patients with congestive heart failure.
J Am Coll Cardiol. 1998;3:1352-6.
(5) Schachter, Michael. Coenzyme Q10.:
www.healthy.net/clinic/therapy
(6) Carper, Jean. Miracle Cures. New York: Harper
Collins, 1997.
(7) Sinatra S. Refractory congestive heart failure successfully
managed with
high dose coenzyme Q10 administration. Mol Aspects
Med.
1997;18:s299-305.
(8) Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients
in classes
III and IV of cardiomyopathy to therapy in
a blind and crossover trial with
coenzyme Q10. Proc Natl Acad Sci U S
A. 1985;82:4240-4.
(9) Langsjoen PH, Vadhanavikit S, Folkers K. Long-term efficacy
and safety
of coenzyme Q10 therapy for idiopathic
dilated cardiomyopathy.
Am J Cardio. 1990;65:521-3.
(10) Soja AM, Mortensen SA. Treatment of congestive heart failure
with
coenzyme Q10 illuminated by
meta-analysis of clinical trials.
Mol Aspects Med.
1997;18:s159-s168.
(11) Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN.
Lack of effect of coenzyme Q10
on left ventricular function in patients
with congestive heart failure. J Am Coll Cardiol. 1999;33:1549-52.
(12) Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R,
Robinson SW, Gottlieb SS.
The effect of coenzyme Q10 in patients with
congestive heart failure.
Ann Intern Med. 2000;132:636-640.
(13) Coenzyme Q10 and Congestive Heart Failure.
Letters to the Editor.
Ann Intern Med.
2000;133:745-746.
(14) American Council on Science and Health. What's the
story? Drug
Supplement Interaction. Nov. 2000.
www.acsh.org.
(15) Engelsen J, Nielsen JD, Hansen KF. Effect of coenzyme Q10 and Ginkgo
biloba on
warfarin dosage in patients on long-term warfarin treatment. A
randomized,
double-blind, placebo-controlled cross-over trial.
Ugeskr
Laeger.
Apr. 2003;165 (18): 1868-71.
(16) Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, Vered
Y,
Vidne BA, Aravot D. Coenyme q10 in patients with
end-stage heart failure
awaiting cardiac transplantation: a
randomized, placebo-controlled study.
Clin Cardiol. May 2004; 27(5): 295-9.
(17)
Zhou Q. Effect of coenzyme Q10 on warfarin hydroxylation in rate
an human liver microsomes.
Current Drug Metabolism, April 2005; Vol. 6
(2), pp. 67-81
(18)
Barak Y. MELAS syndrome: peripheral neuropathy and cytochrome C-oxidase
deficiency: a case report and review of literature. Israel
Journal Of Medical Sciences , 1995 Apr; Vol. 31 (4), pp. 224-9
(19)
Evans R. "Natural" or alternative medications for
migrain prevention. Headache, 2006 Jun;
Vol. 46 (6), pp. 1012-8.
(20)
Damian M. Coenzyme Q10 combined with mild hypothermia after
cardiac arrest: a preliminary study. Circulation,
2004 Nov 9; Vol. 110 (19), pp. 3011-6.
(21)
Tran M. Role of coenzyme Q10 in chronic heart failure, angina,
and hypertension. Pharmacotherapy,
2001 Jul; Vol. 21 (7), pp. 797-806.
(22)
Rosenfeldt F. Systematic review of effect of coenzyme Q10 in
physical exercise, hypertension, and heart failure. Biofactors,
2003; Vol. 18 (1-4), pp. 91-100
(23)
Langsjoen M. Introduction of Coenzyme Q10. faculty.washington.edu/~ely/coenzq10.html.
Last accessed: 3/19/2007.
(24)
Bonakdar R and Guarneri E.. Coenzyme Q10. American
Family Physician. Vol
72, No. Sept. 15, 2005.
(25)
Shinde, Santosh, Kumar, Pawan. Effect of Simvastatin and
Atorvastatin on Coenzyme Q10. Internet
Journal of Cardiology, 2007, Vol. 4 Issue 1.
(26)
Rodriguez M. Beneficial effects of creatine, CoQ10, and lipoic
acid in mitochondrial disorders. Muscle
& Nerve, 2007 Feb; Vol. 35 (2), pp. 235-42
|
.
|
(27)
A randomized clinical trial of coenzyme Q10 and GPI-1485 in
early Parkinson disease. By The
NINDS NET-PD Investigators, Neurology [Neurology], 2007 Jan 2;
Vol. 68 (1), pp. 20-8
(28)
Hershey A, Powers S, Scott W, Vockell A, LeCates, S, Ellinor P,
Segers, A, Burdine D, Manning P, and Kabbouche M. Coenzyme
Q10 Deficiency and Response to Supplementation in Pediatric and
Adolescent Migraine. Headache:
The Journal of Head & Face Pain, Jan2007, Vol. 47 Issue 1,
p73-80.
|
(29)
Bradley R, Oberg E, Calabrese C, Standish L, and Leanna J.
Algorithm for Complementary and Alternative Medicine Practice and
Research in Type 2 Diabetes. Journal
of Alternative & Complementary Medicine, Jan2007, Vol. 13 Issue 1,
p159-176.
(30)
DiMauro S. Approaches to the treatment of mitochondrial
diseases. Muscle & Nerve [Muscle
Nerve], 2006 Sep; Vol. 34 (3), pp. 265-83
(31)
Hathcock J & Shao A. Risk assessment for coenzyme Q10 (Ubiquinone).
Regulatory Toxicology & Pharmacology:
RTP, Aug2006, Vol. 45 Issue 3, p282-288.
(32)
Kaliora A, Dedoussis G, and Schmidt H. Dietary antioxidants in
preventing atherogenesis.
Atherosclerosis, Jul2006, Vol. 187 Issue 1, p1-17.
|
